TY - JOUR
T1 - Precision acute medical care through “-omic” analyses
T2 - a scoping review
AU - Ettingoff, Cole
AU - Von Isenburg, Megan
AU - Birrenkott, Drew
AU - Ata, Hirotaka
AU - Kabrhel, Chris
AU - Safdar, Basmah
AU - Hasegawa, Kohei
AU - Monte, Andrew
AU - Korley, Frederick
AU - Arnold, Cosby Gabrielle
AU - Heitsch, Laura
AU - Strehlow, Matthew
AU - Limkakeng, Alexander T.
N1 - Publisher Copyright:
© 2025 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2025
Y1 - 2025
N2 - Background: -Omics technologies–including genomics, transcriptomics, proteomics, and metabolomics–are increasingly used in acute care settings. However, the current extent of this research has not been systematically assessed. Objectives: To characterize how -omics analyses are applied to acute medical conditions and identify trends, gaps, and implementation barriers. Methods: Eligible studies included human subjects with acute conditions and used -omics biosample analyses for diagnostic, prognostic, or predictive purposes. Feedback from the SAEM Precision Emergency Medicine Consensus Conference informed the search and inclusion criteria. Studies of infectious diseases were excluded for separate analysis. Results: Of 7,531 screened articles, 421 met inclusion criteria. Most were observational cohort studies, with single nucleotide polymorphism analysis being most common. Cardiovascular and trauma-related conditions were frequently studied. Only 12.4% of studies included children, and just 7 focused exclusively on older adults. One-third were conducted outside of emergency departments. Many studies addressed diverse, uncategorized acute conditions. Conclusions: While -omics research in acute care is growing, it remains predominantly observational with limited clinical implementation. Barriers include delayed turnaround times, insufficient EHR integration, and underrepresentation of vulnerable populations. Advancing this field requires cross-disciplinary collaboration, focused research priorities, and investment in implementation studies.
AB - Background: -Omics technologies–including genomics, transcriptomics, proteomics, and metabolomics–are increasingly used in acute care settings. However, the current extent of this research has not been systematically assessed. Objectives: To characterize how -omics analyses are applied to acute medical conditions and identify trends, gaps, and implementation barriers. Methods: Eligible studies included human subjects with acute conditions and used -omics biosample analyses for diagnostic, prognostic, or predictive purposes. Feedback from the SAEM Precision Emergency Medicine Consensus Conference informed the search and inclusion criteria. Studies of infectious diseases were excluded for separate analysis. Results: Of 7,531 screened articles, 421 met inclusion criteria. Most were observational cohort studies, with single nucleotide polymorphism analysis being most common. Cardiovascular and trauma-related conditions were frequently studied. Only 12.4% of studies included children, and just 7 focused exclusively on older adults. One-third were conducted outside of emergency departments. Many studies addressed diverse, uncategorized acute conditions. Conclusions: While -omics research in acute care is growing, it remains predominantly observational with limited clinical implementation. Barriers include delayed turnaround times, insufficient EHR integration, and underrepresentation of vulnerable populations. Advancing this field requires cross-disciplinary collaboration, focused research priorities, and investment in implementation studies.
KW - Omics
KW - genomics
KW - metabolomics
KW - precision diagnostics
KW - prognostics
KW - proteomics
KW - rapid precision care
UR - http://www.scopus.com/inward/record.url?scp=105004836515&partnerID=8YFLogxK
U2 - 10.1080/17410541.2025.2499438
DO - 10.1080/17410541.2025.2499438
M3 - Review article
AN - SCOPUS:105004836515
SN - 1741-0541
VL - 22
SP - 205
EP - 210
JO - Personalized Medicine
JF - Personalized Medicine
IS - 3
ER -